Skip to main content
Fig. 5 | EJNMMI Physics

Fig. 5

From: Maximum tumor-absorbed dose measured by voxel-based multicompartmental dosimetry as a response predictor in yttrium-90 radiation segmentectomy for hepatocellular carcinoma

Fig. 5

Post-treatment images of the patient diagnosed with HCC (Fig. 4): The CT study to assess response at 3 months (A and B) showed a 15-mm focal lesion in segment VII without contrast enhancement that could suggest tumor persistence or recurrence. After hepatic segmentectomy (C and D) performed 9 months after radioembolization, a resection cavity was shown, without focal hepatic lesions suggestive of tumor recurrence. Finally, the pathological study of the surgical piece (E and F) showed a fibronecrotic nodule in relation to the embolization material without the presence of residual neoplasia

Back to article page